Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship
- Author(s)
- Weerdenburg, H; Lindsay, J;
- Details
- Publication Year 2023-07-07,Volume 25,Issue #Suppl 1,Page e14094
- Journal Title
- Transplant Infectious Disease
- Publication Type
- Review
- Abstract
- BACKGROUND: Infectious disease (ID) pharmacists and antimicrobial stewardship (AMS) programs are integral to the infection management of hematopoietic cell transplant (HCT) recipients demonstrating effective implementation of clinical pathways, de-escalation of empirical antibiotics for febrile neutropenia (FN), allergy assessments, and use of rapid diagnostic testing. The HCT procedure is complex, dynamic, and a high risk for infectious complications. Therefore, there is an important role for an ID and AMS pharmacist to collaborate with the primary treating team, with ongoing care, involving the optimal individual patient prophylactic, pre-emptive and treatment management of infections in this high-risk population. CONCLUSION: This review highlights key factors for consideration of ID/AMS Pharmacists in relation to HCT, including important aspects in the evaluation of infection risk prior to transplant, risk from donor sources, length of, and changes in immunosuppression, and potential drug-drug interactions from other essential supportive care therapies.
- Publisher
- Wiley
- Keywords
- antimicrobial; hematopoietic cell transplant; infections; pharmacist
- Department(s)
- Infectious Diseases
- PubMed ID
- 37418600
- Publisher's Version
- https://doi.org/10.1111/tid.14094
- Open Access at Publisher's Site
https://doi.org/10.1111/tid.14094- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-10-24 04:50:21
Last Modified: 2024-09-05 06:55:59